Microscopic Eye Implant Promises Vision Restoration

A Significant Step in Treating Dry Macular Degeneration

Researchers from Keck Medicine at the University of Southern California (USC) have launched a new clinical study testing a microscopic stem cell-based implant that could restore vision for individuals affected by advanced dry macular degeneration. This hair-thin implant aims to replace damaged retinal cells, which are essential for clear central vision.

Age-related macular degeneration is the most common cause of vision loss and blindness among Americans aged 65 and older. The disease progresses over time, affecting central vision and causing blurry areas, dark spots, or blind spots in the visual field. This study will evaluate whether bioengineered stem cells can replace deteriorated retina cells and potentially restore vision.

During the study, physicians will introduce a thin layer of lab-grown retinal cells directly into the retina through an outpatient surgical procedure. “We hope to determine if the stem cell-based implant can not only halt the progression of dry macular degeneration but also improve the vision of patients,” stated Dr. Sun Young Lee, a retinal surgeon and the principal investigator of the study.

Previous studies have shown that the implant is safe, with 27% of participants experiencing improved vision. This new study, which aims to recruit 24 patients, offers hope for those affected by advanced forms of the disease, where treatment options are limited.